Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials Article

sustainable development goals

publication date

  • September 17, 2022

webpage

published in

start page

  • 896

end page

  • 907

volume

  • 400

issue

  • 10356